Literature DB >> 11738452

Investigating sources of variability of monochromatic and transverse chromatic aberrations across eyes.

S Marcos1, S A Burns, P M Prieto, R Navarro, B Baraibar.   

Abstract

Schematic eye models have typically been used to explain the average monochromatic and chromatic imaging properties of the eye. Both monochromatic aberrations and transverse chromatic aberration are known to vary widely across subjects. However, to our knowledge, the ability of schematic eye models to predict these individual variations has not been tested experimentally. We used a spatially resolved refractometer to measure the monochromatic aberrations and the optical transverse chromatic aberration (oTCA) in a group of 15 eyes. By recording the 1st and 4th Purkinje images for five directions of gaze, we also estimated the tilt, misalignment of ocular surfaces (front surface of the cornea and back surface of the lens) and off-axis position of the fovea (angle alpha), as well as pupil centration. We conclude that, contrary to expectations none of those factors are major contributors to the variability in monochromatic aberrations and oTCA in this group of eyes. Simulations show that corneal curvature and corneal conicity are also unlikely to account for the observed relation between monochromatic aberrations and oTCA. Our results suggest an important contribution of corneal irregularities to those aberrations.

Entities:  

Mesh:

Year:  2001        PMID: 11738452     DOI: 10.1016/s0042-6989(01)00133-x

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  9 in total

1.  Pupil location under mesopic, photopic, and pharmacologically dilated conditions.

Authors:  Yabo Yang; Keith Thompson; Stephen A Burns
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

2.  Transverse chromatic offsets with pupil displacements in the human eye: sources of variability and methods for real-time correction.

Authors:  Alexandra E Boehm; Claudio M Privitera; Brian P Schmidt; Austin Roorda
Journal:  Biomed Opt Express       Date:  2019-03-06       Impact factor: 3.732

3.  Verification of the lack of correlation between age and longitudinal chromatic aberrations of the human eye from the visible to the infrared.

Authors:  Masashi Nakajima; Takahiro Hiraoka; Yoko Hirohara; Tetsuro Oshika; Toshifumi Mihashi
Journal:  Biomed Opt Express       Date:  2015-06-25       Impact factor: 3.732

Review 4.  Adaptive optics imaging of the human retina.

Authors:  Stephen A Burns; Ann E Elsner; Kaitlyn A Sapoznik; Raymond L Warner; Thomas J Gast
Journal:  Prog Retin Eye Res       Date:  2018-08-27       Impact factor: 21.198

5.  Longitudinal chromatic aberration of the human eye in the visible and near infrared from wavefront sensing, double-pass and psychophysics.

Authors:  Maria Vinas; Carlos Dorronsoro; Daniel Cortes; Daniel Pascual; Susana Marcos
Journal:  Biomed Opt Express       Date:  2015-02-24       Impact factor: 3.732

6.  Measurement and correction of transverse chromatic offsets for multi-wavelength retinal microscopy in the living eye.

Authors:  Wolf M Harmening; Pavan Tiruveedhula; Austin Roorda; Lawrence C Sincich
Journal:  Biomed Opt Express       Date:  2012-08-13       Impact factor: 3.732

7.  Investigation of the isoplanatic patch and wavefront aberration along the pupillary axis compared to the line of sight in the eye.

Authors:  Maciej Nowakowski; Matthew Sheehan; Daniel Neal; Alexander V Goncharov
Journal:  Biomed Opt Express       Date:  2012-01-03       Impact factor: 3.732

8.  Measurement of Longitudinal Chromatic Aberration in the Last Crystalline Lens Surface Using Hartmann Test and Purkinje Images.

Authors:  Uriel Calderon-Uribe; Geovanni Hernandez-Gomez; Armando Gomez-Vieyra
Journal:  Sensors (Basel)       Date:  2022-03-30       Impact factor: 3.576

Review 9.  Glaucoma: the retina and beyond.

Authors:  Benjamin Michael Davis; Laura Crawley; Milena Pahlitzsch; Fatimah Javaid; Maria Francesca Cordeiro
Journal:  Acta Neuropathol       Date:  2016-08-20       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.